Sign in
4

Changes in Ownership

Nurix Therapeutics, Inc. Filed Acc 0001549595-24-000153

Chief Financial Officer sold 3,546 shares at $24.28 ($86,083)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

van Houte Hans · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-11-01 Sale : show line 1 in the form 10b5-1 −3,546 $24.28 $86,083 33,724 D
Open-market sales · 3,546 sh · avg $24.28 · $86,083
Loading xslF345X05/wk-form4_1730498227.xml…